Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 542,155
  • Shares Outstanding, K 37,857
  • Annual Sales, $ 360 K
  • Annual Income, $ -137,480 K
  • 36-Month Beta 1.74
  • Price/Sales 41.16
  • Price/Cash Flow N/A
  • Price/Book 3.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -1.24
  • Number of Estimates 3
  • High Estimate -1.11
  • Low Estimate -1.32
  • Prior Year -1.38
  • Growth Rate Est. (year over year) +10.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.50 +14.56%
on 01/28/19
15.16 -5.54%
on 01/31/19
-0.26 (-1.78%)
since 01/18/19
3-Month
10.98 +30.42%
on 01/04/19
16.87 -15.12%
on 12/03/18
-1.65 (-10.33%)
since 11/19/18
52-Week
10.98 +30.42%
on 01/04/19
29.10 -50.79%
on 06/20/18
-8.87 (-38.25%)
since 02/16/18

Most Recent Stories

More News
Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA(R) (triamcinolone acetonide extended-release injectable suspension) in Rheumatology and Therapy

-- X-ray data at baseline and Week 52 showed ZILRETTA had no deleterious impact on cartilage or joint structure

FLXN : 14.32 (-2.32%)
Flexion Therapeutics to Ring Nasdaq Stock Market Opening Bell on Tuesday, February 12

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it has been invited to ring the Nasdaq opening bell on Tuesday, February 12, 2019 to commemorate the fifth anniversary of the company's initial...

FLXN : 14.32 (-2.32%)
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to 14 new employees for an aggregate of 51,000 shares of common stock. The Compensation Committee of the Board...

FLXN : 14.32 (-2.32%)
Consolidated Research: 2019 Summary Expectations for Telephone and Data, EMCOR Group, Chart Industries, Alarm, Flexion Therapeutics, and Social Reality -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Telephone and Data Systems,...

SRAX : 3.99 (+1.53%)
TDS : 36.59 (+0.80%)
GTLS : 84.62 (-4.02%)
ALRM : 64.65 (-0.55%)
EME : 68.11 (+0.10%)
FLXN : 14.32 (-2.32%)
Flexion Therapeutics Names Christina Willwerth Chief Strategy Officer

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Christina Willwerth has been named Chief Strategy Officer. Ms. Willwerth joined Flexion in June 2009, and she most recently served as the company's...

FLXN : 14.32 (-2.32%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Alder Biopharmac (ALDR , CLVS , FLXN , LGND , CHRS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ALDR : 13.92 (-2.79%)
CLVS : 24.37 (-4.39%)
FLXN : 14.32 (-2.32%)
Downtrend Call Working As Flexion Therapeu Stock Falls 44.5% (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 6 months, Flexion Therapeu has returned 44.51% as of today's recent price of $13.44.

FLXN : 14.32 (-2.32%)
44.3% Return Seen to Date on SmarTrend Flexion Therapeu Call (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 5 months, Flexion Therapeu has returned 44.34% as of today's recent price of $13.48.

FLXN : 14.32 (-2.32%)
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2018 Revenue and Initial Revenue Guidance for 2019

-- Full-year 2018 revenue estimated to be approximately $22.5 million

FLXN : 14.32 (-2.32%)
Flexion Starts Phase III Enrollment on Zilretta for Hip OA

Flexion (FLXN) initiates enrollment in phase III study on its pain drug, Zilretta, for the treatment of patients suffering hip osteoarthritis.

CPIX : 5.73 (+3.43%)
HKMPF : 22.1000 (-1.78%)
FLXN : 14.32 (-2.32%)
BSTC : 71.50 (-0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade FLXN with:

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

2nd Resistance Point 15.23
1st Resistance Point 14.78
Last Price 14.32
1st Support Level 14.09
2nd Support Level 13.85

See More

52-Week High 29.10
Fibonacci 61.8% 22.18
Fibonacci 50% 20.04
Fibonacci 38.2% 17.90
Last Price 14.32
52-Week Low 10.98

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar